Personalised medicine is at the core of many new MedTech products. By leveraging genetic information and patient data, products are being developed to cater to individual health needs. This trend is driving the development of targeted therapies and customised treatment plans that improve patient outcomes.
When attempting to turn a novel, lab-based test into a market-disrupting, clinical, certified, diagnostic product, our recommendation is to start with the user. At eg, we place huge importance on mapping out the user workflow in relation to the clinical pathway, with special attention to where the test, device and other development aspects intersect. By tailoring different user studies to each stage of your project and incorporating other defined criteria – such as risk levels, use environment and workflow – we regularly transform conceptual and lab-scale set-ups, processes and technologies into robust, marketable products.